Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2000
06/08/2000CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2000EP1006197A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/07/2000EP1006196A2 Retroviral hybrid vectors pseudotyped with LCMV glycoprotein
06/07/2000EP1006194A2 C-erbB-2 external domain: GP75
06/07/2000EP1006182A2 Polypeptide fragments of factor VIIIC, corresponding probes and DNA sequences and DNA constructs
06/07/2000EP1005871A2 Trapped cells and use thereof as a drug
06/07/2000EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
06/07/2000EP1005866A2 Allogeneic and xenogeneic transplantation
06/07/2000EP1005789A2 Quiescent cell populations for nuclear transfer
06/07/2000EP1005561A1 Vector and viral vectors, and packaging cell lines for propagating same
06/07/2000EP1005560A1 Matrix attachment regions
06/07/2000EP1005556A2 Stable biocatalysts for ester hydrolysis
06/07/2000EP1005552A1 Member of the hematopoietin receptor superfamily
06/07/2000EP1005551A2 Tissue factor pathway inhibitor-3
06/07/2000EP1005550A1 Ubc7-like ubiquitin-conjugating enzyme
06/07/2000EP1005549A2 Prostate tumor polynucleotide and antigen compositions
06/07/2000EP1005545A1 Human extracellular matrix-1
06/07/2000EP1005544A1 70 human secreted proteins
06/07/2000EP1005542A1 Apolipoprotein e transgenic animals and assay methods
06/07/2000EP1005540A1 Ikk-beta proteins, nucleic acids and methods
06/07/2000EP1005539A1 IKK-$g(a) PROTEINS, NUCLEIC ACIDS AND METHODS
06/07/2000EP1005538A1 Gene therapy for alleviating erectile dysfunction
06/07/2000EP1005534A1 Method for increasing the efficiency of recombinant aav production
06/07/2000EP1005533A1 Methods for screening nuclear transcription factors for the ability to modulate an estrogen response
06/07/2000EP1005532A1 Isolated nucleic acid molecules encoding ssx family members and uses thereof
06/07/2000EP1005531A2 Method of treating leukocytes, leukocyte compositions and methods of use thereof
06/07/2000EP1005526A1 Direct expression of peptides into culture media
06/07/2000EP1005489A1 Novel polypeptides within the growth factor superfamily
06/07/2000EP1005488A1 Receptor that binds trail
06/07/2000EP1005486A1 Inducible regulatory system and use thereof
06/07/2000EP1005481A1 Methods for the production of aslv reverse transcriptases composed of multiple subunits
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005374A1 Microparticles for delivery of nucleic acid
06/07/2000EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
06/07/2000EP1005365A1 Abundant extracellular products and methods for their production and use
06/07/2000EP1005363A2 Recombinant dimeric envelope vaccine against flaviviral infection
06/07/2000EP1005358A1 Method for preventing and treating hearing loss using a neurturin protein product
06/07/2000EP1005331A1 Transplants coated with autologous endothelial cells
06/07/2000EP0686197B1 Geminivirus-based gene expression system
06/07/2000CN1255542A Process for replicating living things and creating organa with culture-activated cells or cell nucleus
06/07/2000CN1053218C Fatty acyl-coa, fatty alcohol acyltransferases
06/06/2000US6072049 Hepatitis B surface antigen vaccine
06/06/2000US6072047 Nucleotide and amino acid sequence that binds the protein known as tumor necrosis factor-related apoptosis-inducing ligand; for recombinant expression; for purifying protein or suppressing activities
06/06/2000US6072037 Antibodies to the IL-17 receptor
06/06/2000US6072033 Receptor that binds IL-17
06/06/2000US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections
06/06/2000US6071894 Sensor histidine kinase of Staphylococcus aureus
06/06/2000US6071892 Polynucleotides that encode the polypeptide of tyrosyl synthetase have amino acid homology to a known bacillus subtilis tyrosyl trna synthetase protein
06/06/2000US6071891 Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition
06/06/2000US6071889 In vivo genetic modification of growth factor-responsive neural precursor cells
06/06/2000US6071747 Human preadipocytes for developing antiobesity and antidiabetic agents; cells include immortalizing fragment of viral oncogene, promoter from viral oncogene or human vimentin gene, and express certain proteins
06/06/2000US6071745 Contacting eukaryotic cells with isotonic, nuclease-free aqueous solution which has been pretreated with diethyl pyrocarbonate, lyophilizing cells, maintaining under sealed conditions
06/06/2000US6071743 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
06/06/2000US6071736 Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus
06/06/2000US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents
06/06/2000US6071730 Cell ablation using trans-splicing ribozymes
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/06/2000US6071721 Calcium binding protein
06/06/2000US6071720 Polynucleotide coding a polypeptide associated with ionic mobility; for the diagnosis, treatment or prevention of nervous system disorders, cardiovascular disorders and cancer; anticarcinogenic agents
06/06/2000US6071719 Polynucleotide sequence coding a membrane protein; for the treatment and prevention of infections
06/06/2000US6071718 Synthesizing caseins in vivo; constructing expression vector which codes caseins and a peptidase, transforming cells, allowing cleavage of casein product
06/06/2000US6071715 Nucleic acids encoding novel proteins which bind to retinoblastoma protein
06/06/2000US6071705 Method of detecting neurological disease or dysfunction
06/06/2000US6071698 DNA extraction buffer and method of use thereof
06/06/2000US6071691 Screening for modulators of cell differentiation; monitoring expression levels of a marker protein in suppressed cells, monitoring expression of marker protein after incubation with modulator
06/06/2000US6071689 System for improving yield of sexed embryos in mammals
06/06/2000US6071512 Administering replication defective recombinant retrovirion with gene operable linked to control sequence
06/06/2000US6071509 Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor
06/06/2000CA2047683C Neuronal nicotinic acetylcholine receptor compositions containing the beta 4 subunit
06/02/2000WO2000031547A1 Prion protein standard and method of making same
06/02/2000WO2000031296A1 Antisense modulation of interleukin-15 expression
06/02/2000WO2000031285A1 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
06/02/2000WO2000031284A1 Protein expression vector and utilization thereof
06/02/2000WO2000031283A2 Regulatory sequences useful for gene expression in plant embryo tissue
06/02/2000WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors
06/02/2000WO2000031278A1 Zace1: a human metalloenzyme
06/02/2000WO2000031273A2 Process for oxidising terpenes
06/02/2000WO2000031267A1 Insulin production by engineered muscle cells
06/02/2000WO2000031266A1 Human parathyroid hormone modifications, preparation and use
06/02/2000WO2000031265A1 Urotensins ii of mammals and their uses
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031258A2 Human orphan g protein-coupled receptors
06/02/2000WO2000031253A2 Mutation of the parkin gene, compositions, methods and uses
06/02/2000WO2000031250A1 Nucleic acid fragments, recombinant vector containing the same and method for promoting the expression of structural gene by using the same
06/02/2000WO2000031248A1 Humanized monoclonal antibodies
06/02/2000WO2000031247A2 Recombinant methods and materials for producing epothilone and epothilone derivatives
06/02/2000WO2000031241A2 Polypeptides having choline oxidase activity and nucleic acids encoding same
06/02/2000WO2000031240A1 Immortalized brain endothelial cells
06/02/2000WO2000031237A2 Method of cloning porcine animals
06/02/2000WO2000031236A2 Vectors for gene mutagenesis and gene discovery by gene trapping
06/02/2000WO2000031235A2 Nucleotide and protein sequences of nogo genes and methods based thereon
06/02/2000WO2000031137A1 Amino-terminal modified parathyroid hormone (pth) analogs
06/02/2000WO2000031133A2 Potassium channel interactors and uses therefor
06/02/2000WO2000031127A2 Protein fragments for use in protein targeting
06/02/2000WO2000031126A2 Suppression of xenotransplant rejection
06/02/2000WO2000031124A2 Peptides that modulate the interaction of b class ephrins and pdz domains
06/02/2000WO2000031115A1 Methods of identifying antigen gene sequences
06/02/2000WO2000031108A1 Dna molecules encoding hg51, a g-protein-coupled receptor
06/02/2000WO2000030695A1 Mucosal epithelial cell sheet and method for producing the same
06/02/2000WO2000030675A2 Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
1 ... 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 ... 1827